9 results - M - W - D

TC

Stat

Stk

Ins

Fil

+d

+w

+m

+q

+h

+y

avg

S%ret129-3-7-12-19-32-50-20
S%wins10089100898910094

Filing Date

T Date

Ticker

Sector

Ind

Industry

Owner

oSt

Rel

Title

T

TVal

Price

L

Qty

oc

Own

H

r2y

r1y

r6m

r3m

r6w

r3w

r7d

r3d

f1d

f1w

f1m

f3m

f6m

f1y

12/4/15 16:25
12/3/15
CLSNHealthDrugPharmaceutical PreparationsEgwu, Inc. Fka Egen, Inc.ALTS-122.080-602,422D-48-17-193131111-10-52-2-25-26-62
12/3/15 14:39
12/1/15
CLSNHealthDrugPharmaceutical PreparationsEgwu, Inc. Fka Egen, Inc.ALTS-322.150-15-12,427D-49-16-1831511122-2-8-7-37-34-67
12/1/15 13:11
11/30/15
CLSNHealthDrugPharmaceutical PreparationsEgwu, Inc. Fka Egen, Inc.ALTS-432.150-20-12,442D-39-15-11917192318-3-18-15-42-39-67
9/9/15 13:28
9/8/15
CLSNHealthDrugPharmaceutical PreparationsEgwu, Inc. Fka Egen, Inc.ALTS-212.110-1002,462D-65-34-22-15-15-286-2-2-20-14-32-44
8/19/15 16:00
8/17/15
CLSNHealthDrugPharmaceutical PreparationsEgwu, Inc. Fka Egen, Inc.ALTS-222.190-1002,472D-56-30-22-180-10-2-3-4-10-4-14-38-39
8/17/15 15:23
8/13/15
CLSNHealthDrugPharmaceutical PreparationsEgwu, Inc. Fka Egen, Inc.ALTS-452.230-20-12,482D-59-30-7-14-5-121-1-2-10-5-17-46-44
8/7/15 13:10
8/5/15
CLSNHealthDrugPharmaceutical PreparationsEgwu, Inc. Fka Egen, Inc.ALTS-232.261-1002,502D-60-260-5-4-8-75-5-3-16-17-47-47
2/24/15 14:45
2/20/15
CLSNHealthDrugPharmaceutical PreparationsEgwu, Inc. Fka Egen, Inc.ALTS-6593.301-200-72,512D-43-15-3242538309-4-8-12-14-35-59
3/21/13 17:01
3/19/13
CLSNHealthDrugPharmaceutical PreparationsWeaver Gregory LNJOCFOS-401.061-37-1000D-54-35-78-86-812-44-2-3-25139-23

DDerivative transaction in filing (usually option exercise)
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
AAmended filing
EError detected in filing
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top

Contact